reports
Aurora Spine Corporation Announces First Quarter 2024 Financial Result...
Aurora Spine Corporation Announces First Quarter 2024 Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for first quarter ended March 31, 2024. All figures are in U.S. dollars. Financial and Business Highlights Positive EBITDAC – Q1 2024 EBITDAC was $117,171 as compar...
Aurora Spine Corporation Schedules Conference Call to Update Investors...
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results CARLSBAD, Calif. , May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its first quarter fiscal 2024 financial results that ended March 31, 2024. Management will host the conference call on Tuesday May 14, 2024 at 11...
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Fina...
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for fiscal 2023 ended December 31, 2023. The company experienced strong, successive, quarter over quarter revenue growth, while overcoming early year obs...
Aurora Spine Corp: 2 directors
Two Directors at Aurora Spine Corp sold/bought 825,000 shares at 0.240USD. The significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Aurora Spine Corporation Celebrates Second Anniversary of Initial Impl...
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C. Trent Northcutt, CEO and President at Aurora Spine said, "It's a signifi...
Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Match...
Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office CARLSBAD, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its second United States Patent No: 11,850,162 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology. Aur...
The United States Patent Office Grants New Patent for Aurora Spine’s T...
The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube CARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”. Aurora Spine’s Ghost Tube™ was designed to provide superior anchoring with a translucent thermoplastic body and non-slipping tita...
AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SO...
AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING CARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North American Neuromodulation Society (“NANS”) Annual Meeting from January 18-21 in Las Vegas, Nevada. The NANS Annual Meeting is a prominent medical conference that brings together healthcare professionals, ...
Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference
Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference CARLSBAD, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be attending the J.P. Morgan Healthcare Conference in San Francisco, CA the week of January 8-11, 2024. The conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-gr...
Aurora Spine Corporation Announces Newly Published Paper on First 6-mo...
Aurora Spine Corporation Announces Newly Published Paper on First 6-month Clinical Evaluation of its ZIP™ Fusion Implant CARLSBAD, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the publication of the first 6-month clinical evaluation of its ZIP™ fusion implant in the Journal of Pain Research. Lumbar interlaminar decompression with interspinous fixation is an established safe and effective treatme...
Aurora Spine Grants Stock Options
Aurora Spine Grants Stock Options Carlsbad, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announces that it has granted options (the "Options") to acquire 1,000,000 common shares of the Company to Trent J. Northcutt, President & CEO. The Options are exercisable at a price of CDN$0.395 per common share and vest one third on the first, second and third annual anniversaries from the date of grant. The Options have a ...
Aurora Spine Corporation Announces Third Quarter Fiscal 2023 Financial...
Aurora Spine Corporation Announces Third Quarter Fiscal 2023 Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Management to host conference call for investors in coming week, details to follow - CARLSBAD, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its third quarter fiscal 2023 ended September 30, 2023. All figures are ...
Aurora Spine Corporation Schedules Conference Call to Update Investors...
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results CARLSBAD, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced today announced it has scheduled a conference call to update investors and discuss its third quarter fiscal 2023 financial results that ended September 30, 2023. Management will host the conference call on Wednes...
AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING
AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING Carlsbad, California, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE: ASG) (OTCQB: ASAPF) is pleased to announce that it has completed a non-brokered private placement offering of units ("Units") for gross proceeds of approximately CDN$1.9 million (the "Offering"). Pursuant to the Offering, the Company has issued 6,445,939 Units at a price of CDN$0.30 per Unit. Each Unit is comprised of one common share of the Company and one common share purchase warrant of the Compan...
Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Jo...
Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it is in full commercial release of its proprietary SiLO TFX™ MIS Sacroiliac Joint Fixation Device system. The patented, minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System is intended for sacroiliac joint fusion for conditions incl...
Aurora Spine Corporation Schedules Conference Call to Update Investors...
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Second Quarter Fiscal Year 2023 Financial Results CARLSBAD, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its second quarter fiscal 2023 financial results that ended June 30, 2023. Management will host the conference call on Tuesday, August 29, 2023 ...
Aurora Spine Corporation Announces Second Quarter Fiscal 2023 Financia...
Aurora Spine Corporation Announces Second Quarter Fiscal 2023 Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Management to host conference call for investors in coming week, details to follow - CARLSBAD, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its second quarter fiscal 2023 ended June 30, 2023. All figures are in ...
Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicent...
Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study Carlsbad, Calif, June 28, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that the first patient has been enrolled for its multicenter study of DEXA-CTM Cervical Interbody System. The commencement of the enrollment of patients indicates that the company has received all necessary approvals to launch the study, which will initially include ...
Aurora Spine Corporation Announces First Quarter Fiscal 2023 Financial...
Aurora Spine Corporation Announces First Quarter Fiscal 2023 Financial Results Management to host conference call today, May 24, 2023 at 12:00 PM ET NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its first quarter fiscal 2023 ended March 31, 2023. All figures are in U.S. dollars. ...
Aurora Spine Corporation Schedules Release of First Quarter Fiscal Yea...
Aurora Spine Corporation Schedules Release of First Quarter Fiscal Year 2023 Financial Results and Conference Call CARLSBAD, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release for the first quarter fiscal 2023 ended March 31, 2023, on Wednesday, May 24, 2023. Management will host a conference call that day at 12:00 p.m. Eastern Time to discuss the result...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.